ES2156150T3 - Combinacion terapeutica que contiene interferon. - Google Patents
Combinacion terapeutica que contiene interferon.Info
- Publication number
- ES2156150T3 ES2156150T3 ES94902910T ES94902910T ES2156150T3 ES 2156150 T3 ES2156150 T3 ES 2156150T3 ES 94902910 T ES94902910 T ES 94902910T ES 94902910 T ES94902910 T ES 94902910T ES 2156150 T3 ES2156150 T3 ES 2156150T3
- Authority
- ES
- Spain
- Prior art keywords
- interfered
- therapeutic combination
- combination containing
- human
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3476—Powered trocars, e.g. electrosurgical cutting, lasers, powered knives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3494—Trocars; Puncturing needles with safety means for protection against accidental cutting or pricking, e.g. limiting insertion depth, pressure sensors
- A61B17/3496—Protecting sleeves or inner probes; Retractable tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1487—Trocar-like, i.e. devices producing an enlarged transcutaneous opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B17/3211—Surgical scalpels, knives; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/0019—Moving parts vibrating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMBINACION TERAPEUTICA, MAS PARTICULARMENTE UNA TERAPIA DE COMBINACION QUE CONTIENE EL USO DE INTERFERONA HUMANA. LA TERAPIA COMPRENDE EL TRATAMIENTO DE LAS CONDICIONES SUSCEPTIBLES AL TRATAMIENTO CON INTERFERONA HUMANA, CON UNA COMBINACION DE INTERFERONA HUMANA Y UN DEPURADOR DE RADICAL LIBRE O UN PRECURSOR O UN INDUCTOR DEL MISMO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226729A GB9226729D0 (en) | 1992-12-22 | 1992-12-22 | Therapeutic combination |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2156150T3 true ES2156150T3 (es) | 2001-06-16 |
Family
ID=10727038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94902910T Expired - Lifetime ES2156150T3 (es) | 1992-12-22 | 1993-12-20 | Combinacion terapeutica que contiene interferon. |
Country Status (24)
Country | Link |
---|---|
US (1) | US5830455A (es) |
EP (1) | EP0675730B1 (es) |
JP (2) | JP2849214B2 (es) |
KR (1) | KR100309059B1 (es) |
CN (1) | CN1094642A (es) |
AT (1) | ATE199643T1 (es) |
AU (1) | AU680858B2 (es) |
CA (1) | CA2152389A1 (es) |
DE (1) | DE69330032T2 (es) |
ES (1) | ES2156150T3 (es) |
FR (1) | FR2699407A1 (es) |
GB (1) | GB9226729D0 (es) |
HR (1) | HRP931510A2 (es) |
HU (1) | HUT72965A (es) |
IL (1) | IL108114A (es) |
IT (1) | IT1261949B (es) |
MY (1) | MY141415A (es) |
NO (1) | NO952469L (es) |
PL (1) | PL309398A1 (es) |
RU (1) | RU2145235C1 (es) |
TW (1) | TW286283B (es) |
WO (1) | WO1994014473A1 (es) |
YU (1) | YU79393A (es) |
ZA (1) | ZA939583B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
DE4325547C2 (de) * | 1993-07-29 | 1997-11-27 | Max Planck Gesellschaft | Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen |
US6020205A (en) * | 1998-04-10 | 2000-02-01 | Immunosciences Lab, Inc. | Determination of intracellular antioxidant levels |
RU2156134C2 (ru) * | 1998-05-12 | 2000-09-20 | ООО "Формавит" | Биофармацевтический препарат на основе живой культуры bacillus и способ лечения заболевания инфекционной природы |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) * | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
WO2002044717A1 (en) * | 2000-12-01 | 2002-06-06 | Cornell Research Foundation | Animal model for flaviviridae infection |
US6759061B2 (en) * | 2001-08-31 | 2004-07-06 | Renew Life, Inc. | Liver function improvement formulation |
JP2005504087A (ja) * | 2001-09-28 | 2005-02-10 | イデニクス(ケイマン)リミテツド | 4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物 |
WO2003043573A2 (en) * | 2001-11-16 | 2003-05-30 | The Uab Research Foundation | Xanthine oxidase inhibition |
EP1536804A4 (en) | 2002-06-28 | 2007-10-31 | Idenix Cayman Ltd | 2'-C-METHYL-3'-O-L-VALINESTER-RIBOFURANOSYLCYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS |
NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
EP2799442A1 (en) | 2002-06-28 | 2014-11-05 | IDENIX Pharmaceuticals, Inc. | Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections |
JP2004155777A (ja) * | 2002-10-16 | 2004-06-03 | Asahi Kasei Pharma Kk | C型慢性肝炎治療剤 |
HUE033832T2 (en) | 2002-11-15 | 2018-01-29 | Idenix Pharmaceuticals Llc | 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation |
WO2004050101A2 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
MXPA05006230A (es) | 2002-12-12 | 2005-09-20 | Idenix Cayman Ltd | Proceso para la produccion de nucleosidos ramificados-2'. |
WO2004084796A2 (en) * | 2003-03-28 | 2004-10-07 | Pharmasset Ltd. | Compounds for the treatment of flaviviridae infections |
ES2586668T3 (es) | 2003-05-30 | 2016-10-18 | Gilead Pharmasset Llc | Análogos de nucleósidos fluorados modificados |
CN1816538B (zh) * | 2003-07-22 | 2011-05-25 | 协和发酵生化株式会社 | 病毒感染症的预防或者治疗用组合物 |
AU2004258750A1 (en) * | 2003-07-25 | 2005-02-03 | Centre National De La Recherche Scientifique -Cnrs | Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C |
WO2005018330A1 (en) * | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
JP2005104852A (ja) * | 2003-09-29 | 2005-04-21 | Kyowa Hakko Kogyo Co Ltd | モービリウィルス感染症の予防または治療用組成物 |
WO2005107742A1 (en) | 2004-05-05 | 2005-11-17 | Yale University | Novel antiviral helioxanthin analogs |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
MX2007003085A (es) | 2004-09-14 | 2007-08-02 | Pharmasset Inc | Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados. |
JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
CU23432B6 (es) | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
WO2007075876A2 (en) | 2005-12-23 | 2007-07-05 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
EP2376514A2 (en) | 2008-12-23 | 2011-10-19 | Pharmasset, Inc. | Nucleoside analogs |
NZ593647A (en) | 2008-12-23 | 2013-08-30 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
MX2011006891A (es) | 2008-12-23 | 2011-10-06 | Pharmasset Inc | Fosforamidatos de nucleosidos. |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
AU2011235112B2 (en) | 2010-03-31 | 2015-07-09 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
US10838095B2 (en) | 2010-08-05 | 2020-11-17 | Pgs Geophysical As | Wavefield deghosting of seismic data recorded using multiple seismic sources at different water depths |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US8809354B2 (en) | 2011-12-31 | 2014-08-19 | Sheikh Riazuddin | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
NZ716840A (en) | 2013-08-27 | 2017-06-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526205A (en) * | 1974-11-07 | 1978-09-27 | Searle & Co | Treatment of interferon-like material |
US4100150A (en) * | 1975-11-04 | 1978-07-11 | G. D. Searle & Co. | Stabilization of interferon against mechanical stress using thioctic acid |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
CH666814A5 (it) * | 1986-07-24 | 1988-08-31 | Inpharzam Int Sa | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
US4985241A (en) * | 1986-11-21 | 1991-01-15 | Cetus Corporation | Therapeutic combination of free-radical scavenger and tumor necrosis factor |
CA1321349C (en) * | 1986-11-21 | 1993-08-17 | Robert Zimmerman | Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
US5248697A (en) * | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
ES2082908T3 (es) * | 1990-11-19 | 1996-04-01 | Manz Galvano Technik Gmbh | Dispositivo de drenaje y llaves de paso para tambores de inmersion en el tratamiento por galvanizado y/o quimico de superficies exteriores de piezas en masa. |
-
1992
- 1992-12-22 GB GB929226729A patent/GB9226729D0/en active Pending
-
1993
- 1993-04-12 TW TW082102718A patent/TW286283B/zh active
- 1993-12-20 ES ES94902910T patent/ES2156150T3/es not_active Expired - Lifetime
- 1993-12-20 DE DE69330032T patent/DE69330032T2/de not_active Expired - Fee Related
- 1993-12-20 YU YU79393A patent/YU79393A/sh unknown
- 1993-12-20 WO PCT/GB1993/002600 patent/WO1994014473A1/en active IP Right Grant
- 1993-12-20 EP EP94902910A patent/EP0675730B1/en not_active Expired - Lifetime
- 1993-12-20 HU HU9501841A patent/HUT72965A/hu unknown
- 1993-12-20 KR KR1019950702659A patent/KR100309059B1/ko not_active IP Right Cessation
- 1993-12-20 PL PL93309398A patent/PL309398A1/xx unknown
- 1993-12-20 AU AU57076/94A patent/AU680858B2/en not_active Ceased
- 1993-12-20 RU RU95113492A patent/RU2145235C1/ru active
- 1993-12-20 AT AT94902910T patent/ATE199643T1/de not_active IP Right Cessation
- 1993-12-20 JP JP6514930A patent/JP2849214B2/ja not_active Expired - Lifetime
- 1993-12-20 CA CA002152389A patent/CA2152389A1/en not_active Abandoned
- 1993-12-21 IT ITRM930840A patent/IT1261949B/it active IP Right Grant
- 1993-12-21 MY MYPI93002794A patent/MY141415A/en unknown
- 1993-12-21 HR HR931510A patent/HRP931510A2/hr not_active Application Discontinuation
- 1993-12-21 IL IL10811493A patent/IL108114A/en active IP Right Grant
- 1993-12-21 CN CN93121281A patent/CN1094642A/zh active Pending
- 1993-12-21 FR FR9315349A patent/FR2699407A1/fr active Pending
- 1993-12-21 ZA ZA939583A patent/ZA939583B/xx unknown
- 1993-12-21 JP JP5322685A patent/JPH06234657A/ja active Pending
-
1995
- 1995-06-20 NO NO952469A patent/NO952469L/no not_active Application Discontinuation
-
1996
- 1996-09-06 US US08/706,645 patent/US5830455A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ITRM930840A0 (it) | 1993-12-21 |
HU9501841D0 (en) | 1995-08-28 |
JPH06234657A (ja) | 1994-08-23 |
TW286283B (es) | 1996-09-21 |
ITRM930840A1 (it) | 1995-06-21 |
IL108114A (en) | 1999-12-31 |
US5830455A (en) | 1998-11-03 |
KR100309059B1 (ko) | 2002-06-20 |
AU5707694A (en) | 1994-07-19 |
NO952469D0 (no) | 1995-06-20 |
MY141415A (en) | 2010-04-30 |
YU79393A (sh) | 1996-10-09 |
EP0675730B1 (en) | 2001-03-14 |
GB9226729D0 (en) | 1993-02-17 |
RU2145235C1 (ru) | 2000-02-10 |
CA2152389A1 (en) | 1994-07-07 |
PL309398A1 (en) | 1995-10-02 |
ATE199643T1 (de) | 2001-03-15 |
DE69330032D1 (de) | 2001-04-19 |
JP2849214B2 (ja) | 1999-01-20 |
IL108114A0 (en) | 1994-04-12 |
NO952469L (no) | 1995-06-20 |
DE69330032T2 (de) | 2001-09-06 |
HUT72965A (en) | 1996-06-28 |
IT1261949B (it) | 1996-06-04 |
JPH08504799A (ja) | 1996-05-21 |
AU680858B2 (en) | 1997-08-14 |
CN1094642A (zh) | 1994-11-09 |
WO1994014473A1 (en) | 1994-07-07 |
EP0675730A1 (en) | 1995-10-11 |
FR2699407A1 (fr) | 1994-06-24 |
HRP931510A2 (en) | 1995-12-31 |
ZA939583B (en) | 1995-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2156150T3 (es) | Combinacion terapeutica que contiene interferon. | |
ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
PT797439E (pt) | Utilizacao de pramipexote como agente neuroprotector | |
BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
DE69308290D1 (de) | Vorsehen einer optimierten schrittmacherfrequenz, die mit den physiologischen erfordernissen des patienten variiert | |
ES2165910T3 (es) | Administracion nasal y ocular de cetamina para el tratamiento del dolor y para la desintoxicacion. | |
NO20032027L (no) | Effektive antitumorbehandlinger | |
ES2093774T3 (es) | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. | |
ES2133412T3 (es) | 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma. | |
MX9602442A (es) | Un tratamiento con fluoroquinolona a dosis unica elevada. | |
DK0637306T3 (da) | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi | |
AU2807492A (en) | Use of misoprostol for the treatment of allergy | |
ES2172558T3 (es) | Lubricante compatible con radiaciones para dispositivos medicos. | |
ES2191206T3 (es) | Nueva utilizacion de la creatina. | |
DE68918562T2 (de) | Menschliche myeloperoxidase und therapeutische verwendung. | |
ES2152315T3 (es) | Xamoneline tartrato. | |
SE8802040D0 (sv) | New use | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
ES2156584T3 (es) | Androgenos para estimular el sistema nervioso central. | |
ES2042715T3 (es) | Remedio medico veterinario y humano que tiene una actividad antivirial y antitumoral que contiene 2,6-diamino-3-fenil-azo-piridina. | |
IT223885Z2 (it) | Maschera per elettrostimolazione del viso. | |
IT8011954V0 (it) | Manipolo per apparecchi terapeutici e di trattamenti estetici | |
ITMI920033A1 (it) | Dispositivo stimolatore di tessuti del corpo umano | |
UA12937A (uk) | Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом | |
IT8519180A0 (it) | Impiego della benzidamina nel trattamento delle infezioni da gardnerella vaginalis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 675730 Country of ref document: ES |